m+Medelevator.RU
← Поиск публикаций
Scientific reports · 2025

Machine learning prediction of mortality in pediatric fungemia using the Candida score.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Al-Sofyani Khouloud Abdulrahman, Muzaffar Ibrahim Hussain Ali, Baqasi Abdulrahman Mohammedsaeed, Al Fulayyih Saleh, Uddin Mohammed Shahab

Аннотация

Pediatric fungemia in pediatric intensive care units (PICUs) carries high mortality. We evaluated whether the Candida Score, combined with clinical variables, predicts mortality after diagnosis using a prespecified multivariable logistic regression (primary model) and benchmarked discrimination against Random Forest and Gradient Boosting Machine. We analyzed 85 pediatric fungemia cases from a PICU (2016-2020). The prespecified primary model was multivariable logistic regression with predefined covariates; Random Forest and Gradient Boosting Machine were exploratory comparators. Discrimination was evaluated on a held-out test set and by 10-fold cross-validation and bootstrapping. In 85 cases, the median age was 6 months and median weight 4.8 kg; 62.4% were male. Candida albicans was the most prevalent species (37.6%). Of the subjects, 39 (45.9%) died and 46 (54.1%) survived. On the held-out test set (n = 17), logistic regression achieved accuracy 0.735 and AUC 0.800. Random Forest achieved AUC 0.861 (precision 1.000; recall 0.778), and Gradient Boosting achieved AUC 0.847 (precision 0.875; recall 0.778). Internal validation (10-fold cross-validation and bootstrap resampling) supported model stability.Conclusion Integrating the Candida Score with clinical predictors shows potential for mortality risk stratification after fungemia diagnosis. In this single-center cohort, Random Forest yielded the highest discrimination on the test set. Findings are exploratory and require external validation in larger, multicenter studies before clinical use.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты